Medtronic commenced EU launch of AVILA™ interbody fusion devices, intended for for L2-S1 levels in open and minimally invasive anterior and oblique lumbar interbody fusion.
AVILA integrates with the PYRAMID®+4 Anterior Lumbar Plate, posterior fixation systems such as CD HORIZON® LONGITUDE® II and with Medtronic’s biologics, including Grafton® Demineralized Bone Matrix and Mastergraft®.
AVILA is approved under the CE Mark for interbody fusion with autogenous bone graft and/or bone graft substitute in adults, and is intended for use with supplemental fixation instrumentation.
Medtronic commenced EU launch of AVILA™ interbody fusion devices, intended for for L2-S1 levels in open and minimally invasive anterior and oblique lumbar interbody fusion.
AVILA integrates with the PYRAMID®+4 Anterior Lumbar Plate, posterior fixation systems such as CD HORIZON® LONGITUDE® II and with Medtronic's biologics, including Grafton®...
Medtronic commenced EU launch of AVILA™ interbody fusion devices, intended for for L2-S1 levels in open and minimally invasive anterior and oblique lumbar interbody fusion.
AVILA integrates with the PYRAMID®+4 Anterior Lumbar Plate, posterior fixation systems such as CD HORIZON® LONGITUDE® II and with Medtronic’s biologics, including Grafton® Demineralized Bone Matrix and Mastergraft®.
AVILA is approved under the CE Mark for interbody fusion with autogenous bone graft and/or bone graft substitute in adults, and is intended for use with supplemental fixation instrumentation.
Copy to clipboard 
